Malignant ascites

a 2-year review from a teaching hospital

Simon L. Parsons, Martin W. Lang, Robert J. C. Steele

    Research output: Contribution to journalArticle

    77 Citations (Scopus)

    Abstract

    In this retrospective review of 164 consecutive patients with malignant ascites it has been shown that ovarian ascites accounts for 28% of the total and is associated with a significantly improved survival compared with other groups (P<0.001). Non-ovarian ascites is associated with a very poor prognosis and many patients in this group are unsuitable for aggressive treatment. In 49% of patients, ascites will be the presenting feature requiring further investigation to ascertain the primary tumour. Thorough investigation of female patients should be performed in order to identify all patients with an ovarian primary so that appropriate chemotherapy can be given. However, thorough investigation in male patients is not justifiable.
    Original languageEnglish
    Pages (from-to)237-239
    Number of pages3
    JournalEuropean Journal of Surgical Oncology
    Volume22
    Issue number3
    DOIs
    Publication statusPublished - Jun 1996

    Fingerprint

    Ascites
    Teaching Hospitals
    Drug Therapy
    Survival
    Neoplasms

    Keywords

    • Adult
    • Aged
    • Ascites
    • Breast Neoplasms
    • Digestive System Neoplasms
    • Female
    • Humans
    • Male
    • Middle Aged
    • Neoplasms
    • Ovarian Neoplasms
    • Prognosis
    • Retrospective Studies
    • Survival Rate

    Cite this

    Parsons, Simon L. ; Lang, Martin W. ; Steele, Robert J. C. / Malignant ascites : a 2-year review from a teaching hospital. In: European Journal of Surgical Oncology. 1996 ; Vol. 22, No. 3. pp. 237-239.
    @article{e55d696e394c4a86ba5db416dee5d6f1,
    title = "Malignant ascites: a 2-year review from a teaching hospital",
    abstract = "In this retrospective review of 164 consecutive patients with malignant ascites it has been shown that ovarian ascites accounts for 28{\%} of the total and is associated with a significantly improved survival compared with other groups (P<0.001). Non-ovarian ascites is associated with a very poor prognosis and many patients in this group are unsuitable for aggressive treatment. In 49{\%} of patients, ascites will be the presenting feature requiring further investigation to ascertain the primary tumour. Thorough investigation of female patients should be performed in order to identify all patients with an ovarian primary so that appropriate chemotherapy can be given. However, thorough investigation in male patients is not justifiable.",
    keywords = "Adult, Aged, Ascites, Breast Neoplasms, Digestive System Neoplasms, Female, Humans, Male, Middle Aged, Neoplasms, Ovarian Neoplasms, Prognosis, Retrospective Studies, Survival Rate",
    author = "Parsons, {Simon L.} and Lang, {Martin W.} and Steele, {Robert J. C.}",
    year = "1996",
    month = "6",
    doi = "10.1016/S0748-7983(96)80009-6",
    language = "English",
    volume = "22",
    pages = "237--239",
    journal = "European Journal of Surgical Oncology",
    issn = "0748-7983",
    publisher = "Elsevier",
    number = "3",

    }

    Malignant ascites : a 2-year review from a teaching hospital. / Parsons, Simon L.; Lang, Martin W.; Steele, Robert J. C.

    In: European Journal of Surgical Oncology, Vol. 22, No. 3, 06.1996, p. 237-239.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Malignant ascites

    T2 - a 2-year review from a teaching hospital

    AU - Parsons, Simon L.

    AU - Lang, Martin W.

    AU - Steele, Robert J. C.

    PY - 1996/6

    Y1 - 1996/6

    N2 - In this retrospective review of 164 consecutive patients with malignant ascites it has been shown that ovarian ascites accounts for 28% of the total and is associated with a significantly improved survival compared with other groups (P<0.001). Non-ovarian ascites is associated with a very poor prognosis and many patients in this group are unsuitable for aggressive treatment. In 49% of patients, ascites will be the presenting feature requiring further investigation to ascertain the primary tumour. Thorough investigation of female patients should be performed in order to identify all patients with an ovarian primary so that appropriate chemotherapy can be given. However, thorough investigation in male patients is not justifiable.

    AB - In this retrospective review of 164 consecutive patients with malignant ascites it has been shown that ovarian ascites accounts for 28% of the total and is associated with a significantly improved survival compared with other groups (P<0.001). Non-ovarian ascites is associated with a very poor prognosis and many patients in this group are unsuitable for aggressive treatment. In 49% of patients, ascites will be the presenting feature requiring further investigation to ascertain the primary tumour. Thorough investigation of female patients should be performed in order to identify all patients with an ovarian primary so that appropriate chemotherapy can be given. However, thorough investigation in male patients is not justifiable.

    KW - Adult

    KW - Aged

    KW - Ascites

    KW - Breast Neoplasms

    KW - Digestive System Neoplasms

    KW - Female

    KW - Humans

    KW - Male

    KW - Middle Aged

    KW - Neoplasms

    KW - Ovarian Neoplasms

    KW - Prognosis

    KW - Retrospective Studies

    KW - Survival Rate

    U2 - 10.1016/S0748-7983(96)80009-6

    DO - 10.1016/S0748-7983(96)80009-6

    M3 - Article

    VL - 22

    SP - 237

    EP - 239

    JO - European Journal of Surgical Oncology

    JF - European Journal of Surgical Oncology

    SN - 0748-7983

    IS - 3

    ER -